Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB · BSE: 532305 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹404.35
Market cap: ₹3,516 Cr
Revenue (annual): ₹641.3 Cr
Net profit (annual): ₹41.42 Cr
P/E (TTM): 61.3×Sector 50.4×
Promoter holding: 42.93%-0.06% QoQ
FII holding: 10.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 4 Financial Results 2 Other Announcement 1 Management Change 1 Earnings Call 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

17 Aug 2026 14:09 IST BSE

Earnings Call

Ind-Swift Laboratories Investor Presentation: Key Takeaways

ISLL is transitioning from an API player to a pure-play Finished Dosage Formulation (FDF) manufacturer. Post-API business divestment, company is net debt-free with significant growth in EBITDA margins.

Call: Guides 50% growth

Open call summary → Read the filing ↗